数字健康必威手机APP

To understand treatment switching patterns and the underlying drivers of switching decisions in multiple sclerosis, IQVIA combined “automated listening” and processing with manual analysis to gather data from social media websites, advocacy group forums and patient blogs. We compared language referring to switching between oral, injectable and IV therapies and extracted over more than 25,000 data points — more than 10,000 of which were relevant to the study objectives. The study revealed that treatment switching was most common for injectable therapy users, primarily due to side effects and lack of efficacy. Following our analysis, the company has invested in developing a command center to conduct further research via automated social listening combined with manual analysis.